Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS

Table 2

PROactive heart failure data [4].

	Pio/placebo (%)	value
Any heart failure report	11/8	<0.0001
Heart failure not requiring hospitalization	5/3	0.003
Heart failure requiring hospitalization	6/4	0.007
Fatal heart failure	1/1	0.634